BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib
Keywords: AML, acute myeloid leukemia; ATR, ATR serine/threonine kinase; ATM, ATM serine/threonine kinase, (ataxia telangiectasia mutated); BM, bone marrow; BRCA1, breast cancer 1, early onset; BRCA2, breast cancer 2, early onset; BSA, bovine serum albumin; CD45, p